Advertisement
UK markets close in 7 hours 56 minutes
  • FTSE 100

    8,087.36
    +46.98 (+0.58%)
     
  • FTSE 250

    19,624.15
    -95.22 (-0.48%)
     
  • AIM

    754.12
    -0.57 (-0.08%)
     
  • GBP/EUR

    1.1657
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2500
    +0.0037 (+0.30%)
     
  • Bitcoin GBP

    51,402.07
    -2,016.90 (-3.78%)
     
  • CMC Crypto 200

    1,391.53
    +8.95 (+0.65%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.98
    +0.17 (+0.21%)
     
  • GOLD FUTURES

    2,334.60
    -3.80 (-0.16%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,290.20
    +88.93 (+0.52%)
     
  • DAX

    18,008.55
    -80.15 (-0.44%)
     
  • CAC 40

    8,076.47
    -15.39 (-0.19%)
     

Are Medical Stocks Lagging Humana (HUM) This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Humana (HUM) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.

Humana is one of 1153 companies in the Medical group. The Medical group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Humana is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for HUM's full-year earnings has moved 0.5% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

ADVERTISEMENT

Based on the latest available data, HUM has gained about 1.5% so far this year. In comparison, Medical companies have returned an average of -1.5%. This means that Humana is outperforming the sector as a whole this year.

Addus HomeCare (ADUS) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 9.1%.

Over the past three months, Addus HomeCare's consensus EPS estimate for the current year has increased 2.4%. The stock currently has a Zacks Rank #2 (Buy).

To break things down more, Humana belongs to the Medical - HMOs industry, a group that includes 7 individual companies and currently sits at #104 in the Zacks Industry Rank. This group has lost an average of 3.5% so far this year, so HUM is performing better in this area.

On the other hand, Addus HomeCare belongs to the Medical - Outpatient and Home Healthcare industry. This 18-stock industry is currently ranked #153. The industry has moved +6% year to date.

Humana and Addus HomeCare could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Humana Inc. (HUM) : Free Stock Analysis Report

Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research